CLINICAL EXPERIENCES ON THE TREATMENT WITH TICARCILLIN (TIPC) AGAINST SEVERE BRONCHOPULMONARY INFECTIOUS DISEASES

DOI Web Site
  • NAGAHAMA FUMIO
    Department of Respiratory Division, National Sapporo Hospital Hokkaido Cancer center, Sapporo
  • YASUDA SHINYA
    Department of Respiratory Division, National Sapporo Hospital Hokkaido Cancer center, Sapporo
  • NAKABAYASHI TAKEHITO
    Department of Respiratory Division, National Sapporo Hospital Hokkaido Cancer center, Sapporo
  • KOROKU TETSUSHI
    Department of Respiratory Division, National Sapporo Hospital Hokkaido Cancer center, Sapporo
  • SAITO TAKAHISA
    Department of Respiratory Division, National Sapporo Hospital Hokkaido Cancer center, Sapporo
  • KAGAMI YUICHI
    Department of Respiratory Division, National Sapporo Hospital Hokkaido Cancer center, Sapporo

Bibliographic Information

Other Title
  • 難治性気管支肺感染症に対するTicarcillinの治験
  • ナンジセイ キカンシ ハイ カンセンショウ ニ タイスル Ticarcilli

Search this article

Abstract

Seven cases of severe, hardly treated pulmonary infectious diseases, including three cases of diffuse panbronchiolitis, were treated with TIPC, which was used intravenously by one shot or/and drip infusion, at total dosage of 42-132 g, for 7-22 days. All but one case, of severe lung abscess at the end stage of lung cancer, exhibited the effective clinical results, from the points of view as subjective and objective findings, chest X-ray findings and bacteriological changes in sputa.<BR>None was observed side effects and was affected on liver and kidney functions and blood pictures by using TIPC.

Journal

  • CHEMOTHERAPY

    CHEMOTHERAPY 25 (9), 2493-2498, 1977

    Japanese Society of Chemotherapy

Details 詳細情報について

Report a problem

Back to top